Your browser doesn't support javascript.
Characteristics of Reported Deaths Among Fully Vaccinated Persons With Coronavirus Disease 2019-United States, January-April 2021.
François Watkins, Louise K; Mitruka, Kiren; Dorough, Layne; Bressler, Sara S; Kugeler, Kiersten J; Sadigh, Katrin S; Birhane, Meseret G; Nolen, Leisha D; Fischer, Marc.
  • François Watkins LK; COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Mitruka K; COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Dorough L; COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Bressler SS; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USAand.
  • Kugeler KJ; COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Sadigh KS; COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Birhane MG; COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Nolen LD; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Fischer M; COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis ; 75(1): e645-e652, 2022 08 24.
Article in English | MEDLINE | ID: covidwho-1722274
ABSTRACT

BACKGROUND:

Vaccines against coronavirus disease 2019 (COVID-19) are highly efficacious, but severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections do occur after vaccination. We characterized COVID-19 cases among fully vaccinated persons with an outcome of death.

METHODS:

We analyzed COVID-19 cases voluntarily reported to the Centers for Disease Control and Prevention by US health departments from 1 January to 30 April 2021. We included cases among US residents with a positive SARS-CoV-2 test result ≥14 days after completion of an authorized primary vaccine series and who had a known outcome (alive or dead) as of 31 May 2021. When available, specimens were sequenced for viral lineage and death certificates were reviewed for cause(s) of death.

RESULTS:

Of 8084 fully vaccinated persons with reported COVID-19 during the surveillance period, 245 (3.0%) died. Compared with patients who remained alive, those who died were older (median age, 82 vs 57 years;), more likely to reside in a long-term care facility (51% vs 18%), and more likely to have ≥1 underlying health condition associated with risk for severe disease (64% vs 24%) (all P < .01). Among 245 deaths, 191 (78%) were classified as COVID-19 related. Of 106 deaths with available death certificates, COVID-19 was listed for 81 deaths (77%). There were no differences in the type of vaccine administered or the most common viral lineage (B.1.1.7).

CONCLUSIONS:

COVID-19 deaths are rare in fully vaccinated persons, occurring most commonly in those with risk factors for severe disease, including older age and underlying health conditions. All eligible persons should be fully vaccinated against COVID-19 and follow other prevention measures to mitigate exposure risk.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid